查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1908778

乳房攝影市場規模、佔有率和趨勢分析報告：按技術、最終用途、地區和細分市場預測（2026-2033 年）

Breast Imaging Market Size, Share & Trends Analysis Report By Technology (Ionizing, Non Ionizing), By End Use (Hospitals, Breast Care Centers, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 97 Pages | 商品交期: 2-10個工作天內

價格

乳房攝影診斷市場概況

全球乳房攝影成像市場預計到 2025 年價值 58.8 億美元，預計到 2033 年將達到 120.3 億美元。

預計從 2026 年到 2033 年，乳房影像市場將以 9.7% 的複合年成長率成長。乳癌發病率上升、乳房攝影影像領域的技術突破以及多家機構對乳癌篩檢計畫的投資等因素正在推動乳房攝影影像市場的成長。

根據世界癌症研究基金會（WCRF）的數據，預計到2030年，全球整體乳癌病例將達到約210萬例。國際癌症研究機構（IARC）的一份新報告預測，到2050年，全球乳癌病例將增加38%，年死亡人數將增加68%。預計這一趨勢將在預測期內推動乳房攝影影像市場的成長。

乳癌及其他乳房相關疾病發生率的不斷上升預計將顯著推動乳房攝影影像市場的擴張。根據美國國家乳癌基金會（National 乳癌 Cancer Foundation, Inc.）2025年6月發布的數據，預計美國約有八分之一的女性在一生中會被診斷出罹患乳癌。此外，國際癌症研究機構（IARC）預測，2022年至2050年間，美國乳癌發生率將成長27.8%，到2050年將達到約350,693例。癌症病例數量的顯著成長預計將推動美國對乳房磁振造影（MRI）檢查的需求。

技術創新正在推動乳房攝影市場的成長，而對更早期、更精準的癌症檢測的需求不斷成長，更是推動了這一成長。分子乳房攝影、人工智慧輔助診斷和高清乳房攝影顯示等創新技術正在提升臨床信心，並減少解讀難題。隨著醫療機構將精準醫療和篩檢效率置於優先地位，這些先進工具的應用正在加速普及，並塑造乳癌檢測和治療的未來。

對混合成像系統開發的廣泛研究蘊藏著巨大的成長機會，並有助於市場擴張。影像技術的最新發展趨勢徹底革新了治療的性質和方法。結合電腦斷層掃描、MRI和PET掃描等多種影像方式來觀察器官代謝資料和解剖特徵變得日益重要。此外，這些整合成像方式提高了乳房攝影影像的品質、患者的舒適度並降低了輻射劑量。這些優勢促使全球製造商致力於推出能夠提高乳癌診斷靈敏度和準確性的新產品。例如，DeepHealth計劃於2025年2月在歐洲市場推出其“診斷套件”，該套件提供了一個具有統一、工作流程最佳化的放射科工作空間的下一代PACS系統。該公司還計劃擴大其人工智慧驅動的端到端乳房X光攝影診斷解決方案「SmartMammo」的普及範圍，進一步將基於人工智慧的檢測功能和臨床決策支援整合到常規成像工作流程中。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章乳房攝影診斷市場變數、趨勢和範圍

  • 市場譜系展望
    • 母市場展望
  • 市場動態
  • 乳房攝影市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析

第4章乳房攝影診斷市場：依技術分類的估算與趨勢分析

  • 全球乳房攝影診斷市場：技術變革分析
  • 全球乳房攝影診斷市場規模及趨勢分析（依技術分類，2021-2033 年）
  • 電離
    • 全視野數位乳房攝影
    • 模擬乳房攝影
    • 正電子放射乳房攝影術
    • 電電阻掃描
    • 錐狀射束CT
    • 正子斷層掃描和電腦斷層掃描
    • 3D乳房斷層合成
    • MBI/BSGI
  • 非電離
    • MRI
    • 熱成像
    • 超音波
    • 光學成像
    • 自動全乳超音波

第5章乳房攝影：依最終用途分類的估算與趨勢分析

  • 全球乳房攝影影像市場：依最終用途分類的差異分析
  • 全球乳房攝影診斷市場規模及趨勢分析（按最終用途分類），2021-2033年
  • 醫院
    • 醫院市場估計與預測（2021-2033）
  • 診斷影像中心
    • 診斷影像中心市場估計與預測（2021-2033）
  • 乳房護理中心
    • 乳房護理中心市場估計與預測（2021-2033）

第6章乳房攝影診斷市場：區域估算與趨勢分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析（2021-2033）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭情勢

  • 對主要市場參與企業近期趨勢和影響的分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商概況
    • 主要經銷商和通路合作夥伴名單
    • Key customers
    • Global Key company market share analysis, 2024
    • GE HealthCare
    • Siemens Healthineers
    • Philips Healthcare
    • Hologic, Inc.
    • Fujifilm Holdings Corp.
    • SonoCine, Inc.
    • Toshiba Corporation（Canon Inc.）
    • Dilon Technologies, Inc.
    • SonoCine, Inc.
    • Aurora Imaging Technology, Inc.
  • 熱力圖分析/企業市場分析
  • 2025年企業市場占有率預測分析
  • 其他主要市場參與者名單
Product Code: 978-1-68038-146-7

Breast Imaging Market Summary

The global breast imaging market size was estimated at USD 5.88 billion in 2025 and is projected to reach USD 12.03 billion by 2033, growing at a CAGR of 9.7% from 2026 to 2033. Factors such as the rising prevalence of breast cancer, technological breakthroughs in the domain of breast imaging, and investment from several organizations in breast cancer screening programs drive the breast imaging market.

According to the World Cancer Research Fund (WCRF), by 2030, the number of cases of breast cancer is expected to reach about 2.1 million globally. According to a new report from the International Agency for Research on Cancer (IARC), breast cancer cases are expected to increase by 38 percent globally by 2050, with annual deaths from the disease projected to rise by 68 percent. This aspect is expected to contribute to the growth of the breast imaging market over the forecast period.

The growing prevalence of breast cancer and other breast-related abnormalities is expected to drive the expansion of the breast imaging market significantly. According to data published by the National Breast Cancer Foundation, Inc. in June 2025, approximately 1 in 8 women in the U.S. is expected to be diagnosed with breast cancer during their lifetime. In addition, projections from the International Agency for Research on Cancer estimate a 27.8% increase in breast cancer incidence in the U.S. between 2022 and 2050, with cases expected to reach approximately 350,693 by 2050. This substantial rise in cancer cases is anticipated to fuel the demand for breast magnetic resonance imaging procedures across the country.

Technological advancements are driving the growth of the breast imaging market, supported by increasing demand for earlier and more accurate cancer detection. Innovations such as molecular breast imaging, AI-assisted diagnostics, and enhanced breast imaging displays are improving clinical confidence and reducing interpretation challenges. As healthcare providers prioritize precision medicine and screening efficiency, these advanced tools continue to accelerate adoption and shape the future of breast cancer detection and care.

Widespread research in the development of hybrid imaging systems provides high growth opportunities and also aids the market growth. Recent developments in imaging technology have completely revolutionized the nature of treatment and how it is approached. To view the metabolic data and anatomical characteristics of the organs, it has become more crucial to combine imaging methods such as CT scans, MRIs, PET, and others. Furthermore, the quality of breast pictures, patient comfort, and patient dose have all been enhanced by these integrated imaging modalities. Thereby, owing to these advantages, manufacturers across the globe are concentrating more on the introduction of new products to improve the sensitivity and precision of breast cancer diagnostics. For instance, in February 2025, DeepHealth plans to introduce its Diagnostic Suite to the European market, offering a next-generation PACS system with a unified, workflow-optimized radiology workspace. The company also aims to expand access to SmartMammo, its AI-driven end-to-end mammography diagnostic solution, further integrating AI-enabled detection and clinical decision support into routine imaging workflows.

Global Breast Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast imaging market report based on technology, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Ionizing
    • Full-field Digital Mammography
    • Analog Mammography
    • Positron Emission Mammography
    • Electric Impedance Tomography
    • Cone-beam Computed Tomography
    • Positron Emission Tomography & Computed Tomography
    • 3D Breast Tomosynthesis
    • MBI/BSGI
  • Non Ionizing
    • MRI
    • Thermography
    • Ultrasound
    • Optical Imaging
    • Automated Whole-Breast Ultrasound
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Breast Care Centers
  • Diagnostic Imaging Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Breast Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of breast cancer
      • 3.2.1.2. Technological advancements in the field of breast imaging
      • 3.2.1.3. Investments and initiatives from various organizations in breast cancer screening campaigns
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Risk of adverse effects from radiation exposure
      • 3.2.2.2. High cost of imaging systems
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Growing number of clinical trials
      • 3.2.3.2. Growing awareness of early detection
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Shortage of trained radiologists
  • 3.3. Breast Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Breast Imaging Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Breast Imaging Market Technology Movement Analysis
  • 4.3. Global Breast Imaging Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 4.4. Ionizing
    • 4.4.1. Ionizing market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.2. Full-Field Digital Mammography
      • 4.4.2.1. Full-field digital mammography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.3. Analog Mammography
      • 4.4.3.1. Analog mammography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.4. Positron Emission Mammography
      • 4.4.4.1. Positron emission mammography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.5. Electric Impedance Tomography
      • 4.4.5.1. Electric impedance tomography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.6. Cone-Beam Computed Tomography
      • 4.4.6.1. Cone-beam computed tomography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.7. Positron Emission Tomography & Computed Tomography
      • 4.4.7.1. Positron emission tomography & computed tomography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.8. 3D Breast Tomosynthesis
      • 4.4.8.1. 3D breast tomosynthesis market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.9. MBI/BSGI
      • 4.4.9.1. MBI/BSGI market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.5. Non Ionizing
    • 4.5.1. Non Ionizing market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.2. MRI
      • 4.5.2.1. MRI market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.3. Thermography
      • 4.5.3.1. Thermography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.4. Ultrasound
      • 4.5.4.1. Ultrasound market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.5. Optical Imaging
      • 4.5.5.1. Optical imaging market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.6. Automated Whole-Breast Ultrasound
      • 4.5.6.1. Automated whole-breast ultrasound market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Breast Imaging: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Breast Imaging Market End Use Movement Analysis
  • 5.3. Global Breast Imaging Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.5. Diagnostic Imaging Centers
    • 5.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.6. Breast Care Centers
    • 5.6.1. Breast care centers market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Breast Imaging Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 6.3. North America
    • 6.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Competitive scenario
      • 6.3.2.3. Regulatory framework
      • 6.3.2.4. Reimbursement scenario
      • 6.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Competitive scenario
      • 6.3.3.3. Regulatory framework
      • 6.3.3.4. Reimbursement scenario
      • 6.3.3.5. Canada market estimates and forecasts, 2021 - 2033
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Competitive scenario
      • 6.3.4.3. Regulatory framework
      • 6.3.4.4. Reimbursement scenario
      • 6.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Competitive scenario
      • 6.4.1.3. Regulatory framework
      • 6.4.1.4. Reimbursement scenario
      • 6.4.1.5. UK market estimates and forecasts, 2021 - 2033
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Competitive scenario
      • 6.4.2.3. Regulatory framework
      • 6.4.2.4. Reimbursement scenario
      • 6.4.2.5. Germany market estimates and forecasts, 2021 - 2033
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Competitive scenario
      • 6.4.3.3. Regulatory framework
      • 6.4.3.4. Reimbursement scenario
      • 6.4.3.5. France market estimates and forecasts, 2021 - 2033
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Competitive scenario
      • 6.4.4.3. Regulatory framework
      • 6.4.4.4. Reimbursement scenario
      • 6.4.4.5. Italy market estimates and forecasts, 2021 - 2033
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Competitive scenario
      • 6.4.5.3. Regulatory framework
      • 6.4.5.4. Reimbursement scenario
      • 6.4.5.5. Spain market estimates and forecasts, 2021 - 2033
    • 6.4.6. Denmark
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Competitive scenario
      • 6.4.6.3. Regulatory framework
      • 6.4.6.4. Reimbursement scenario
      • 6.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Competitive scenario
      • 6.4.7.3. Regulatory framework
      • 6.4.7.4. Reimbursement scenario
      • 6.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Competitive scenario
      • 6.4.8.3. Regulatory framework
      • 6.4.8.4. Reimbursement scenario
      • 6.4.8.5. Norway market estimates and forecasts, 2021 - 2033
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement scenario
      • 6.5.1.5. Japan market estimates and forecasts, 2021 - 2033
    • 6.5.2. India
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. India market estimates and forecasts, 2021 - 2033
    • 6.5.3. China
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. China market estimates and forecasts, 2021 - 2033
    • 6.5.4. South Korea
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Competitive scenario
      • 6.5.4.3. Regulatory framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Competitive scenario
      • 6.5.5.3. Regulatory framework
      • 6.5.5.4. Reimbursement scenario
      • 6.5.5.5. Australia market estimates and forecasts, 2021 - 2033
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Competitive scenario
      • 6.5.6.3. Regulatory framework
      • 6.5.6.4. Reimbursement scenario
      • 6.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement scenario
      • 6.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. UAE market estimates and forecasts, 2021 - 2033
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Global Key company market share analysis, 2024
    • 7.3.4. GE HealthCare
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Siemens Healthineers
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Philips Healthcare
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Hologic, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Fujifilm Holdings Corp.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. SonoCine, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Toshiba Corporation (Canon Inc.)
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Dilon Technologies, Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. SonoCine, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Aurora Imaging Technology, Inc.
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
  • 7.4. Heat Map Analysis/ Company Market Position Analysis
  • 7.5. Estimated Company Market Share Analysis, 2025
  • 7.6. List of Other Key Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 4 North America breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 5 North America breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 6 U.S breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 7 U.S breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 8 Canada breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 9 Canada breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 10 Mexico breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 11 Mexcio breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 12 Europe breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 13 Europe breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 14 Europe breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 15 UK breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 16 UK breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 17 Germany breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 18 Germany breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 19 France breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 20 France breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 21 Italy breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 22 Italy breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 23 Spain breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 24 Spain breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 25 Sweden breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 26 Sweden breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 27 Denmark breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 28 Denmark breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 29 Norway breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 30 Norway breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 31 Asia Pacific breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 32 Asia Pacific breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 33 Asia Pacific breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 34 Japan breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 35 Japan breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 36 China breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 37 China breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 38 India breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 39 India breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 40 Australia breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 41 Australia breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 42 South Korea breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 43 South Korea breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 44 Thailand breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 45 Thailand breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 46 Latin America breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 47 Latin America breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 48 Latin America breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 49 Brazil breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 50 Brazil breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 51 Argentina breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 52 Argentina breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 53 Middle East & Africa breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 54 Middle East & Africa breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 55 Middle East & Africa breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 56 South Africa breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 57 South Africa breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 58 Saudi Arabia breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 59 Saudi Arabia breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 60 UAE breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 61 UAE breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 62 Kuwait breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 63 Kuwait breast imaging market, by end use, 2021 - 2033 (USD million)

List of Figures

  • Fig. 1 Breast imaging market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market summary (2025)
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Reimbursement pathway
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Breast imaging market: Technology movement analysis
  • Fig. 17 Breast imaging market technology outlook: Key takeaways
  • Fig. 18 Ionizing market, 2021 - 2033 (USD Million)
  • Fig. 19 Full-field digital mammography market, 2021 - 2033 (USD Million)
  • Fig. 20 Analog mammography market, 2021 - 2033 (USD Million)
  • Fig. 21 Positron emission mammography market, 2021 - 2033 (USD Million)
  • Fig. 22 Electric impedance tomography market, 2021 - 2033 (USD Million)
  • Fig. 23 Cone-beam computed tomography market, 2021 - 2033 (USD Million)
  • Fig. 24 Positron emission tomography & computed tomography market, 2021 - 2033 (USD Million)
  • Fig. 25 3D breast tomosynthesis market, 2021 - 2033 (USD Million)
  • Fig. 26 MBI/BSGI market, 2021 - 2033 (USD Million)
  • Fig. 27 Non Ionizing market, 2021 - 2033 (USD Million)
  • Fig. 28 MRI market, 2021 - 2033 (USD Million)
  • Fig. 29 Thermography market, 2021 - 2033 (USD Million)
  • Fig. 30 Ultrasound market, 2021 - 2033 (USD Million)
  • Fig. 31 Optical imaging market, 2021 - 2033 (USD Million)
  • Fig. 32 Automated whole-breast ultrasound market, 2021 - 2033 (USD Million)
  • Fig. 33 Breast imaging market: End use movement analysis
  • Fig. 34 Breast imaging market end use outlook: Key takeaways
  • Fig. 35 Ionizing market, 2021 - 2033 (USD Million)
  • Fig. 36 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 37 Diagnostic imaging centers market, 2021 - 2033 (USD Million)
  • Fig. 38 Breast care centers market, 2021 - 2033 (USD Million)
  • Fig. 39 Regional Outlook, 2025 & 2033
  • Fig. 40 Regional market: Key takeaways
  • Fig. 41 North America breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 43 Canada breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 45 UK breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 46 Germany breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 47 France breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 48 Italy breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 50 Sweden breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 52 Norway breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 55 China breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 56 India breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 57 Australia breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 58 South Korea breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 59 Thailand breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 60 Latin America breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 61 Brazil breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 62 Mexico breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 63 Argentina breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 64 Middle East & Africa breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 65 South Africa breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 67 UAE breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 68 Kuwait breast imaging market, 2021 - 2033 (USD Million)